| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.056 | 0.07 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | 0.064 | 0.07 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | 0.056 | 0.07 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.08 |
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | 0.079 | 0.08 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.08 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.058 | 0.08 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | 0.065 | 0.08 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.08 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.064 | 0.08 |